Cam Gallagher, President at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 23,104 shares at $11.54 ($267K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Seasonal sale ($267k) by President — this insider has traded ZNTL in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.54 | 11,552 | $133K | 50.0% |
| 2 | $11.54 | 11,552 | $133K | 50.0% |
| Total | $11.54 avg | 23,104 | $267K | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |
| ZNTL | SELL | 2023-02-14 | $475K | — | Filing → |